双相情感障碍的科学与治疗
摘要
双相情感障碍是一种严重的精神科疾病，影响着全球约1%的人口，其特征是情绪、精力和感知的极端波动。本期内容涵盖双相情感障碍的生物学机制、两种主要临床亚型、锂盐作为治疗药物的里程碑式发现，以及该疾病背后的神经环路机制。文中还将双相情感障碍与重度抑郁症和边缘型人格障碍加以区分。
核心要点
- 双相情感障碍患者的自杀风险是普通人群的20至30倍，因此早期识别至关重要。
- 双相一型的定义为躁狂发作持续7天或以上；双相二型涉及持续4天或更短的轻躁狂发作，通常伴随重度抑郁发作。
- 双相情感障碍患者有相当长的时间处于无症状状态——双相一型约为53%，双相二型约为45%——这使得诊断尤为困难。
- 双相情感障碍的遗传率约为85%，远高于重度抑郁症（同卵双胞胎的一致率为20%至45%），提示存在强烈的遗传易感性。
- 锂盐于1949年被偶然发现，至今仍是一线治疗药物，但因其毒性风险需要严密监测血药浓度。
- 双相情感障碍涉及内感受神经环路的进行性萎缩，损害患者感知自身情绪和生理状态的能力。
- 边缘型人格障碍可能与双相情感障碍相似，但区别在于：边缘型人格障碍的情绪发作存在外部触发因素，而双相情感障碍的发作可以在没有任何诱因的情况下出现。
- 双相二型常被误诊为重度抑郁症，原因在于轻躁狂发作短暂（约占患者时间的4%至5%），而抑郁发作占主导地位（约50%的时间）。
详细笔记
双相情感障碍的定义
- 双相情感障碍（又称双相抑郁症）表现为情绪、精力和感知的适应不良性波动。
- 影响全球约1%的人口；发病年龄通常在20至25岁之间，但发病越早，预示病程越持久。
- 发病年龄越小 = 该障碍成为个体心理稳定特征的可能性越高。
双相一型与双相二型
双相一型
-
定义为躁狂发作持续7天或以上。
-
需要满足以下7项症状类别中的至少3项：
- 注意力分散 — 注意力迅速转移至任何刺激
- 冲动性 — 过度的、非典型性的购买行为或举动（例如购买10台以上空气炸锅、预订多次国际旅行）
- 夸大妄想 — 对自身特殊地位或能力的妄想性信念（例如相信自己当天下午就会获得普利策奖）
- 思维奔逸 — 在毫无逻辑过渡的情况下，在不相关的话题之间快速跳跃
- 激越 — 极度的躯体性坐立不安，无法保持静止；可伴有偏执
- 睡眠需求减少 — 部分患者可连续7天以上完全不睡眠，却毫不在意
- 快速迫促性言语 — 如机关枪般快速说话，没有给对话留下任何空间
-
躁狂发作必须无法用创伤性脑损伤、癫痫发作、非法药物（如可卡因、苯丙胺）或皮质类固醇来更好地解释。
-
不一定伴有抑郁发作——许多双相一型患者在躁狂后回归基线状态，而非陷入抑郁。
双相二型
- 以轻躁狂发作（躁狂持续时间更短或程度更轻，约4天或更少）加上重度抑郁发作为特征。
- 双相二型患者的时间大致分配为：
- 约50%处于抑郁状态
- 约45%无症状
- 约4%至5%处于轻躁狂状态
- 由于轻躁狂阶段短暂而抑郁阶段占主导，双相二型常被误诊为重度抑郁症。
- 抑郁阶段的饮酒自我调节或社会隔离行为可进一步掩盖诊断。
各状态所占时间（来源：Judd等人，《JAMA Psychiatry》）
| 状态 | 双相一型 | 双相二型 |
|---|---|---|
| 无症状 | 约53% | 约45% |
| 抑郁 | 约32% | 约50% |
| 躁狂/轻躁狂 | 约15% | 约4%至5% |
遗传学与遗传率
- 一般人群患病率：双相情感障碍约1%，重度抑郁症约10%至17%。
- 同卵双胞胎一致率：
- 重度抑郁症：20%至45%
- 双相情感障碍：40%至70%
- 双相情感障碍的总体遗传率：约85% — 在所有精神科疾病中居于最高之列。
- 尚未发现单一致病基因；目前认为是一种遗传易感性与环境因素（如早年生活压力、创伤）相互作用的结果。
- 有双相情感障碍一级亲属（父母、兄弟姐妹、双胞胎）的人，个人患病风险显著升高。
双相情感障碍与边缘型人格障碍
- 关键区别：双相情感障碍的发作可以自发出现，无需外部触发因素；而边缘型人格障碍（BPD）的情绪波动几乎总是由环境事件或对人际关系的感知所触发。
- BPD的标志性特征：分裂（Splitting） — 将某人从”理想化”（无可挑剔）状态突然转变为”贬低”（敌人/威胁）状态。
- 两种疾病对当事人来说都会带来极大的痛苦。
- 边缘型人格障碍将在单独的专题节目中进行深入讨论。
锂盐的发现
- John Cade博士，澳大利亚精神科医生，二战战俘，提出假说认为某种尿液中化学物质的积累导致了躁狂。
- 战后，他将躁狂患者与非躁狂患者的尿液注射到豚鼠体内，发现前者的毒性更强。
- 为了稀释用于注射的尿酸，他使用锂制备尿酸锂——并由此发现其对豚鼠具有镇静效果。
- 对照实验证实，单独使用锂就能产生镇静效果。
- 他将锂盐用于人类患者，并记录到躁狂症状显著减轻。
- 发表于：《锂盐在精神激越治疗中的应用》，《澳大利亚医学杂志》，1949年9月3日。
- 美国FDA直到1970年才批准锂盐用于治疗双相情感障碍——整整晚了21年。
- 锂盐从未获得专利，因为它是一种天然存在的元素（元素周期表第3号元素），制药公司缺乏盈利动机。
锂盐的作用机制
- 增加BDNF（脑源性神经营养因子）：为神经可塑性打开通道——它不会制造特定的变化，而是使神经元更有能力响应环境而改变。
- 抗炎作用：抑制神经和脑组织的炎症，而炎症与双相情感障碍的进展密切相关。
- 神经保护作用：帮助神经元抵御兴奋性毒性——这是一种过度活跃的神经环路释放过量钙离子和谷氨酸，导致相关神经元死亡的过程。
- 锂盐需要持续监测血药浓度以防止毒性风险，尤其是在治疗开始后的前3个月。
双相情感障碍的神经环路基础
-
两大主要机制：
- 疾病早期特定神经环路的过度活跃 — 尤其是参与情绪调节和觉醒的神经环路。
- 内感受神经环路的进行性萎缩 — 随着时间推移，在与双相情感障碍共存的第二个和第三个十年中尤为明显。
-
内感受 — 对内部状态（心率、饱腹感、情绪、精力水平）的感知 — 在双相情感障碍患者中逐渐受损。
-
外感受（感知外部世界）受损程度相对较轻。
-
内感受功能的进行性缺损有助于解释，为何处于躁狂发作中的患者往往无法感知自己已数日未眠或说话异常快速。
-
锂盐的
English Original 英文原文
The Science & Treatment of Bipolar Disorder
Summary
Bipolar disorder is a serious psychiatric condition affecting approximately 1% of the population, characterized by extreme shifts in mood, energy, and perception. This episode covers the biology of bipolar disorder, its two main clinical subtypes, the landmark discovery of lithium as a treatment, and the neural circuit mechanisms underlying the condition. The discussion also distinguishes bipolar disorder from major depression and borderline personality disorder.
Key Takeaways
- Bipolar disorder carries a 20–30 times greater risk of suicide than the general population, making early recognition critically important.
- Bipolar 1 is defined by manic episodes lasting 7 days or more; Bipolar 2 involves hypomanic episodes of 4 days or fewer, often paired with major depressive episodes.
- People with bipolar disorder spend significant time symptom-free — roughly 53% (Bipolar 1) and 45% (Bipolar 2) — making diagnosis especially challenging.
- Heritability of bipolar disorder is approximately 85%, far higher than major depression (20–45% concordance in identical twins), suggesting a strong genetic susceptibility.
- Lithium, discovered serendipitously in 1949, remains a frontline treatment but requires careful blood monitoring due to toxicity risks.
- Bipolar disorder involves a progressive atrophy of interoceptive neural circuits, impairing the person’s ability to sense their own emotional and physical states.
- Borderline personality disorder can resemble bipolar disorder but is distinguished by the presence of an external trigger for mood episodes, whereas bipolar episodes can arise without any trigger.
- Bipolar 2 is often misidentified as major depression because hypomanic episodes are brief (~4–5% of the person’s time) and depressive episodes dominate (~50% of the time).
Detailed Notes
Defining Bipolar Disorder
- Bipolar disorder (also called bipolar depression) involves maladaptive shifts in mood, energy, and perception.
- Affects ~1% of the global population; onset typically between ages 20–25, though earlier onset predicts a more persistent course.
- Earlier onset = higher likelihood the disorder becomes a stable feature of the person’s psychology.
Bipolar 1 vs. Bipolar 2
Bipolar 1
-
Defined by manic episodes lasting 7 or more consecutive days.
-
Requires at least 3 of 7 symptom categories to be present:
- Distractibility — rapid shifting of attention to any stimulus
- Impulsivity — excessive, uncharacteristic purchases or actions (e.g., buying 10+ air fryers, booking multiple international trips)
- Grandiosity — delusional beliefs about one’s special status or abilities (e.g., believing they will win a Pulitzer Prize that afternoon)
- Flight of ideas — rapid jumping between unrelated topics without logical transitions
- Agitation — extreme physical restlessness and inability to be still; can involve paranoia
- Decreased need for sleep — some individuals go 7+ days with zero sleep and are unbothered by it
- Rapid pressured speech — machine-gun-like delivery with no space for dialogue
-
Mania must not be better explained by TBI, seizures, illicit drugs (e.g., cocaine, amphetamines), or corticosteroids.
-
Does not always include depressive episodes — many bipolar 1 patients return to baseline rather than dropping into depression.
Bipolar 2
- Characterized by hypomanic episodes (shorter or less intense mania, ~4 days or fewer) plus major depressive episodes.
- People with Bipolar 2 spend approximately:
- ~50% of time depressed
- ~45% symptom-free
- ~4–5% in hypomanic states
- Because hypomanic phases are brief and depressive phases dominate, Bipolar 2 is frequently misdiagnosed as major depression.
- Self-medication with alcohol or isolation during depressive phases can further obscure the diagnosis.
Time Spent in Each State (from Judd et al., JAMA Psychiatry)
| State | Bipolar 1 | Bipolar 2 |
|---|---|---|
| Symptom-free | ~53% | ~45% |
| Depressed | ~32% | ~50% |
| Manic/Hypomanic | ~15% | ~4–5% |
Genetics and Heritability
- General population prevalence: 1% bipolar disorder, 10–17% major depression.
- Identical twin concordance:
- Major depression: 20–45%
- Bipolar disorder: 40–70%
- Overall heritability of bipolar disorder: ~85% — one of the highest of any psychiatric condition.
- No single identified gene; rather, a genetic susceptibility that interacts with environmental factors (e.g., early life stress, trauma).
- Having a first-degree relative (parent, sibling, twin) with bipolar disorder significantly elevates personal risk.
Bipolar Disorder vs. Borderline Personality Disorder
- Key distinction: Bipolar episodes arise spontaneously without an external trigger; borderline personality disorder (BPD) mood shifts are almost always triggered by an environmental event or relationship perception.
- BPD hallmark: Splitting — abruptly shifting someone from “idealized” (can do no wrong) to “devalued” (enemy/threat) status.
- Both conditions involve significant suffering for the individual experiencing them.
- BPD will be covered in a separate dedicated episode.
The Discovery of Lithium
- Dr. John Cade, an Australian psychiatrist and WWII prisoner of war, hypothesized that a buildup of a urinary chemical caused mania.
- After the war, he injected guinea pigs with urine from manic vs. non-manic patients and noted the former was more toxic.
- In attempting to dilute uric acid for injection, he used lithium to create lithium urate — and discovered it had a calming effect on guinea pigs.
- Control experiments confirmed lithium alone produced the calming effect.
- He administered lithium to human patients and documented dramatic reductions in manic symptoms.
- Published: “Lithium Salts in the Treatment of Psychotic Excitement”, Medical Journal of Australia, September 3, 1949.
- The FDA did not approve lithium for bipolar disorder in the US until 1970 — 21 years later.
- Lithium was never patented because it is a naturally occurring element (element #3 on the periodic table), limiting pharmaceutical profit incentive.
How Lithium Works (Mechanisms)
- Increases BDNF (brain-derived neurotrophic factor): Opens the gates for Neuroplasticity 神经可塑性 — it doesn’t create specific changes but makes neurons more capable of changing in response to environment.
- Anti-inflammatory: Suppresses neural and brain tissue Inflammation 炎症, which is implicated in the progression of bipolar disorder.
- Neuroprotective: Helps neurons withstand excitotoxicity — a process in which hyperactive circuits release excess calcium and glutamate, killing the very neurons involved.
- Lithium requires ongoing blood level monitoring due to toxicity risk, especially in the first 3 months of treatment.
Neural Circuit Basis of Bipolar Disorder
-
Two major mechanisms:
- Hyperactivity of certain circuits early in the disease — particularly circuits involved in emotional regulation and arousal.
- Progressive atrophy of interoceptive circuits — over time, especially in the 2nd and 3rd decades of living with bipolar disorder.
-
Interoception — the perception of internal states (heart rate, fullness, mood, energy level) — becomes progressively impaired in people with bipolar disorder.
-
Exteroception (perceiving the external world) remains more intact.
-
The progressive interoceptive deficit helps explain why individuals in a manic episode often cannot perceive that they haven’t slept in days or are speaking abnormally fast.
-
Lithium’s